MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Agios Pharmaceuticals Company Profile (NASDAQ:AGIO)

Consensus Ratings for Agios Pharmaceuticals (NASDAQ:AGIO) (?)
Ratings Breakdown: 6 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $111.80 (0.59% upside)

Analysts' Ratings History for Agios Pharmaceuticals (NASDAQ:AGIO)
Show:
DateFirmActionRatingPrice TargetActions
6/15/2015Canaccord GenuityLower Price TargetHold$103.00 -> $93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Citigroup Inc.Initiated CoverageNeutral$132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015MLV & Co.Initiated CoverageBuy$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Canaccord GenuityDowngradeBuy -> Hold$163.00 -> $103.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015Citigroup Inc.Set Price TargetHold$137.00 -> $132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015MLV & Co.Boost Price TargetBuy$123.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Canaccord GenuitySet Price TargetBuy$163.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Citigroup Inc.DowngradeBuy -> Neutral$93.00 -> $137.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Roth CapitalInitiated CoverageNeutral$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014MLV & Co.Initiated CoverageBuy$123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014JPMorgan Chase & Co.DowngradeOverweight -> Neutral$60.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2014Canaccord GenuityReiterated RatingBuy$97.00 -> $111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014Canaccord GenuityInitiated CoverageBuy$97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Goldman SachsDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2014Citigroup Inc.Initiated CoverageBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2014JPMorgan Chase & Co.Reiterated RatingOverweight$55.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2014Leerink SwannBoost Price Target$51.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2014JPMorgan Chase & Co.UpgradeNeutral -> Overweight$40.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2014JPMorgan Chase & Co.Boost Price Target$35.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2014Leerink SwannBoost Price Target$38.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2013Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2013Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2013JPMorgan Chase & Co.Initiated CoverageNeutral$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2013Goldman SachsInitiated CoverageBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2013 forward)